Spectrum and the Susceptibilities of Microbial Isolates in Cases of Congenital Nasolacrimal Duct Obstruction

Journal of AAPOS

Volumn 10, Issue 5, 2006, Pages 469-472

  Usha, Kim ^a   Smitha, Sankaranarayanan ^a   Shah, Nagendra ^a   Lalitha, Prajna ^a   Kelkar, Rahul ^a  

^a ARAVIND EYE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; OFLOXACIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOLOGY; BACTERIUM ISOLATE; CANDIDA TROPICALIS; CONGENITAL LACRIMAL DUCT OCCLUSION; CONTROLLED STUDY; DACRYOCYSTITIS; FEMALE; FUNGUS ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; LACRIMAL DUCT OCCLUSION; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOLOGICAL TECHNIQUES; CHILD, PRESCHOOL; DACRYOCYSTITIS; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACRIMAL DUCT OBSTRUCTION; MALE; MICROBIAL SENSITIVITY TESTS; NASOLACRIMAL DUCT; PROSPECTIVE STUDIES;

EID: 33750315189     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2006.04.009     Document Type: Article

References (20)

1. Cassidy T.C. Developmental anatomy of the nasolacrimal duct. Arch Ophthalmol 47 (1952) 141-158
2. Cassidy T.C. Dacryocystitis in infancy. Am J Ophthalmol 31 (1948) 773-780
3. Guerry D., and Kendy E.L. Congenital impatency of the nasolacrimal duct. Arch Ophthalmol 39 (1948) 193-204
4. MacEwen C.J., and Young J.D.H. Epiphora in the first year of life. Eye 5 (1991) 596-600
5. Crigler L.W. The treatment of congenital dacryocystitis. JAMA 81 (1923) 23-24
6. Kushner B.J. Congenital nasolacrimal duct obstruction. Arch Ophthalmol 100 (1982) 597-600
7. Steinkogler F.J., Huber E., Huber-Spitzy V., and Kuchar A. The treatment of congenital nasolacrimal duct obstruction. Primary sufficient therapy avoids chronic inflammation and dacryocystorhinostomy. Orbit 13 (1994) 3-10
8. Hartikainen J., Lehtonen O., and Saari M. Bacteriology of lacrimal duct obstruction in adults. Br J Ophthalmol 81 (1997) 37-40
9. Koke M.P. Treatment of occluded nasolacrimal ducts in infants. Arch Ophthalmol 43 (1950) 750-755
10. Petersen R.A., and Robb R.M. The natural course of congenital obstruction of the nasolacrimal duct. J Pediatr Ophthalmol Strabismus 15 (1978) 246-250
11. Kilowatts J.A., and Welsh M.G. Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology 94 (1987) 698-705
12. Bareja U., and Ghose S. Clinicobacteriological correlates of congenital dacryocystitis. Ind J Ophthalmol 38 (1990) 66-69
13. Kuchar A., Lukas J., and Steinkogler F.J. Bacteriology and antibiotic therapy in congenital nasolacrimal duct obstruction. Acta Ophthalmol Scand 78 (2000) 694-698
14. Bale R.N. Dacryocystitis: bacterial study and its relation with nasal pathology. Indian J Ophthalmol 35 (1987) 178-182
15. Blicker J.A., and Buffman F.V. Lacrimal sac, conjunctival and nasal culture results in dacryocystorhinostomy patients. Ophthalmic Plast Recons Surg 9 (1993) 43-46
16. Coden D.J., Hornblass A., and Hass B.D. Clinical bacteriology of dacryocystitis in adults. Ophthal Plast Reconstr Surg 9 (1993) 125-131
17. Huber Spitzy V., Steinkogler F.J., and Haselberger C. The pathogen spectrum in neonatal dacryocystitis. Klin Monatsbl Augenheilkd 190 (1987) 445-446
18. Ghose S., and Mahajan V.M. Fungal flora in congenital dacryocystitis. Indian J Ophthalmol 38 (1990) 189-190
19. Isenberg S.J. The fall and rise of chloramphenicol. J AAPOS 7 (2003) 307-308
20. Mah F.S. Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections. Curr Opin Ophthalmol 15 (2004) 316-320